Jul. 27, 2022

TAS1553

oral RNR subunit interaction inhibitor Ph. I candidate in oncology HTS and SBDD Commun. Biol. Taiho Pharmaceutical Co., Ltd., Tsukuba, JP

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in